Document
IPR2018-00421, No. 2013 Exhibit - PDR Anaprox (P.T.A.B. May. 22, 2018)
Cite Document
IPR2018-00421, No. 2013 Exhibit - PDR Anaprox (P.T.A.B. May. 22, 2018)
+ More Snippets
Document
IPR2018-00421, No. 2004 Exhibit - Patravale 2004 (P.T.A.B. May. 22, 2018)
Cite Document
IPR2018-00421, No. 2004 Exhibit - Patravale 2004 (P.T.A.B. May. 22, 2018)
+ More Snippets
Document
IPR2018-00421, No. 2023 Exhibit - Gennadios 2002 (P.T.A.B. May. 22, 2018)
Cite Document
IPR2018-00421, No. 2023 Exhibit - Gennadios 2002 (P.T.A.B. May. 22, 2018)
+ More Snippets
Document
IPR2018-00421, No. 2016 Exhibit - Naprosyn FDA approval 1976 (P.T.A.B. May. 22, 2018)
Cite Document
IPR2018-00421, No. 2016 Exhibit - Naprosyn FDA approval 1976 (P.T.A.B. May. 22, 2018)
+ More Snippets
Document
IPR2018-00421, No. 2001 Exhibit - Khan Declaration (P.T.A.B. May. 22, 2018)
Cite Document
IPR2018-00421, No. 2001 Exhibit - Khan Declaration (P.T.A.B. May. 22, 2018)
+ More Snippets
Document
IPR2018-00421, No. 2014 Exhibit - PDR Aleve (P.T.A.B. May. 22, 2018)
Cite Document
IPR2018-00421, No. 2014 Exhibit - PDR Aleve (P.T.A.B. May. 22, 2018)
+ More Snippets
Document
IPR2018-00421, No. 2002 Exhibit - Khan CV (P.T.A.B. May. 22, 2018)
Cite Document
IPR2018-00421, No. 2002 Exhibit - Khan CV (P.T.A.B. May. 22, 2018)
+ More Snippets
Document
IPR2018-00421, No. 2012 Exhibit - PDR Naprosyn (P.T.A.B. May. 22, 2018)
Cite Document
IPR2018-00421, No. 2012 Exhibit - PDR Naprosyn (P.T.A.B. May. 22, 2018)
+ More Snippets
Document
IPR2018-00421, No. 2006 Exhibit - Ranucci 1994 (P.T.A.B. May. 22, 2018)
Cite Document
IPR2018-00421, No. 2006 Exhibit - Ranucci 1994 (P.T.A.B. May. 22, 2018)
+ More Snippets
Document
IPR2018-00421, No. 1028-29 Exhibit - Banner Pharmacaps Inc NDA 21 920, Naproxen Sodium Capsules (P.T.A.B. Jan. 14, 2018)
Cite Document
IPR2018-00421, No. 1028-29 Exhibit - Banner Pharmacaps Inc NDA 21 920, Naproxen Sodium Capsules (P.T.A.B. Jan. 14, 2018)
+ More Snippets
Document
IPR2018-00421, No. 1027-28 Exhibit - H Sevelius et al, ¿¿¿Bioavailability of Naproxen Sodium and Its Relationship to Clinical Analgesic Effects,¿¿¿ 10 Br J Clin Pharmac 259 263 1980 (P.T.A.B. Jan...
Cite Document
IPR2018-00421, No. 1027-28 Exhibit - H Sevelius et al, ¿¿¿Bioavailability of Naproxen Sodium and Its Relationship to Clinical Analgesic Effects,¿¿¿ 10 Br J Clin Pharmac 259 263 1980 (P.T.A.B. Jan. 14,
+ More Snippets
Document
IPR2018-00421, No. 1010-11 Exhibit - US Publication No 20040157928 ¿¿¿Kim¿¿¿ (P.T.A.B. Jan. 14, 2018)
Cite Document
IPR2018-00421, No. 1010-11 Exhibit - US Publication No 20040157928 ¿¿¿Kim¿¿¿ (P.T.A.B. Jan. 14, 2018)
+ More Snippets
Document
IPR2018-00421, No. 1013-14 Exhibit - US Patent No 5,641,512 ¿¿¿Cimileuca¿¿¿ (P.T.A.B. Jan. 14, 2018)
Cite Document
IPR2018-00421, No. 1013-14 Exhibit - US Patent No 5,641,512 ¿¿¿Cimileuca¿¿¿ (P.T.A.B. Jan. 14, 2018)
+ More Snippets
Document
IPR2018-00421, No. 1007-8 Exhibit - Prosecution History of EP 1863458 Counterpart of US Patent No 9,693,978 Part B (P.T.A.B. Jan. 14, 2018)
Cite Document
IPR2018-00421, No. 1007-8 Exhibit - Prosecution History of EP 1863458 Counterpart of US Patent No 9,693,978 Part B (P.T.A.B. Jan. 14, 2018)
+ More Snippets
Document
IPR2018-00421, No. 1015-16 Exhibit - US Patent No 6,383,515 ¿¿¿Sawyer¿¿¿ (P.T.A.B. Jan. 14, 2018)
Cite Document
IPR2018-00421, No. 1015-16 Exhibit - US Patent No 6,383,515 ¿¿¿Sawyer¿¿¿ (P.T.A.B. Jan. 14, 2018)
+ More Snippets